Incyte Corp at Evercore ISI HealthCONx Virtual Conference Transcript
Awesome. Hi, everyone. This is Maneka Mirchandaney from the Evercore ISI biotech team. Very pleased to be here with Incyte at a pretty important time for the company with what looks to be a pretty strong start for Opzelura.
From the team, we've got Christiana Stamoulis, who is EVP and CFO; Steven Stein, who is EVP and CMO; and Christine Chiou, who is the Head of IR. Thank you all for joining.
And I really wanted to start with Opzelura since that's clearly been the big area of focus this year. I think we're all kind of watching the IQVIA scripts that seems to be off to a good start for atopic derm. But maybe you can talk a little bit about the initial launch trajectory, how that's going, and some of the early feedback that you're hearing from physicians.
Questions & Answers
Sure. So the launch is going very well. It's a very strong launch, and I'm sure people are looking at the IQVIA
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
